May 25, 2024 | COVID-19, Research, Treatment
Discussion on acknowledged side effects of Covid vaccines and rarity of associated deaths. NY Times article acknowledges belief in rare but serious side effects of Covid vaccines. • 0:04 Challenges in confirming link between reported side effects and vaccines. • 2:36...
May 25, 2024 | COVID-19, Research, Treatment
COVID-19 vaccine prioritization for children based on risk and benefit analysis. High-risk individuals prioritized for full vaccination and boosters every 6-12 months. • 2:13 Medium priority group includes healthy adults under 50-60 for primary series and first...
May 25, 2024 | COVID-19, Research, Treatment
Pfizer's questionable press release timing and revenue update regarding COVID products. The timing of the press release raised questions about burying bad news and lack of transparency. • 0:00 The opening of European markets for PAX loid was highlighted,...
May 25, 2024 | COVID-19, Research, Treatment
Exploring the impact of declining IgG4 levels post-vaccination on immunity and potential risks. Dr. Philip McMillan discusses the significance of IgG4 levels in immunity post-vaccination. • 0:03 Antibody levels post-infection typically average around 300 nanog per...
May 25, 2024 | COVID-19, Research, Treatment
Insights into vaccine regulatory protocols outside of a pandemic from Susan F. Langlois. Susan Langlois started her career in 1972 as a lab technologist at Cana Laboratories. • 2:50 Langlois’ expertise spans from biologicals to medical devices in the...
